Tuesday - April 07, 2026

Systemic Sclerosis Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s, “Systemic Sclerosis Pipeline Insight 2026” report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Systemic Sclerosis pipeline landscape. It covers the Systemic Sclerosis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading

Nailed It Roofing Announces Expert Roofing Services for Haddonfield, NJ Homeowners in Historic Camden County

Nailed It Roofing now serves Haddonfield, NJ — delivering licensed roof replacement, storm damage repair, and free inspections for homeowners throughout Camden County’s historic borough. Nailed It Roofing, a licensed residential roofing contractor serving New Jersey and Pennsylvania, is now … Continue reading

Post-Traumatic Stress Disorder Treatment Pipeline Shows Strong Momentum as 20+ Pharma Companies in the Race | DelveInsight

DelveInsight’s “Post-Traumatic Stress Disorder Pipeline Insight 2026” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in the Post-Traumatic Stress Disorder pipeline landscape. It covers the Post-Traumatic Stress Disorder Pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading

Chronic Obstructive Pulmonary Disease Clinical Trial Pipeline Appears Robust With 65+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s “Chronic Obstructive Pulmonary Disease Pipeline Insight 2026” report provides comprehensive insights about 65+ companies and 70+ pipeline drugs in the Chronic Obstructive Pulmonary Disease pipeline landscape. It covers the Chronic Obstructive Pulmonary Disease pipeline drug profiles, including clinical and … Continue reading

Gastrointestinal Stromal Tumors Clinical Trial Pipeline Expands as 25+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s, “Gastrointestinal Stromal Tumors Pipeline Insight 2026” report provides comprehensive insights about 25+ companies and 28+ pipeline drugs in Gastrointestinal Stromal Tumors pipeline landscape. It covers the Gastrointestinal Stromal Tumors pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading